(Q35053937)

English

Buprenorphine Response as a Function of Neurogenetic Polymorphic Antecedents: Can Dopamine Genes Affect Clinical Outcomes in Reward Deficiency Syndrome (RDS)?

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

6 August 2017

Buprenorphine Response as a Function of Neurogenetic Polymorphic Antecedents: Can Dopamine Genes Affect Clinical Outcomes in Reward Deficiency Syndrome (RDS)? (English)

1 reference

Europe PubMed Central

6 August 2017

1 reference

based on heuristic

inferred from title

1

object named as

Kenneth Blum

1 reference

Europe PubMed Central

6 August 2017

Marlene Oscar-Berman

2

object named as

Marlene Oscar-Berman

1 reference

Europe PubMed Central

6 August 2017

author name string

William Jacobs

3

1 reference

Europe PubMed Central

6 August 2017

Thomas McLaughlin

4

1 reference

Europe PubMed Central

6 August 2017

Mark S Gold

5

1 reference

Europe PubMed Central

6 August 2017

publication date

1 January 2014

1 reference

Europe PubMed Central

6 August 2017

Journal of addiction research & therapy

1 reference

Europe PubMed Central

6 August 2017

5

1 reference

Europe PubMed Central

6 August 2017

Excessive cocaine use results from decreased phasic dopamine signaling in the striatum

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318568

8 July 2018

Withdrawal from Buprenorphine/Naloxone and Maintenance with a Natural Dopaminergic Agonist: A Cautionary Note

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318568

8 July 2018

Dopamine signaling in reward-related behaviors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318568

8 July 2018

Bidirectional modulation of infralimbic dopamine D1 and D2 receptor activity regulates flexible reward seeking

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318568

8 July 2018

Long term Suboxone™ emotional reactivity as measured by automatic detection in speech

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318568

8 July 2018

Post marketing surveillance of sublingual buprenorphine naloxone combination tablets

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318568

8 July 2018

Reward, interrupted: Inhibitory control and its relevance to addictions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318568

8 July 2018

Generational association studies of dopaminergic genes in reward deficiency syndrome (RDS) subjects: selecting appropriate phenotypes for reward dependence behaviors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318568

8 July 2018

Acute pain management in opioid-tolerant patients: a growing challenge

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318568

8 July 2018

Can the chronic administration of the combination of buprenorphine and naloxone block dopaminergic activity causing anti-reward and relapse potential?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318568

8 July 2018

Psychopathological aspects of dopaminergic gene polymorphisms in adolescence and young adulthood

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318568

8 July 2018

Activation instead of blocking mesolimbic dopaminergic reward circuitry is a preferred modality in the long term treatment of reward deficiency syndrome (RDS): a commentary

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318568

8 July 2018

Association between the DRD2 A1 allele and response to methadone and buprenorphine maintenance treatments

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318568

8 July 2018

D2 dopamine receptor gene in psychiatric and neurologic disorders and its phenotypes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318568

8 July 2018

The D2 dopamine receptor gene as a determinant of reward deficiency syndrome.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318568

8 July 2018

Agonists and antagonists differentially regulate the high affinity state of the D2L receptor in human embryonic kidney 293 cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318568

8 July 2018

A successful treatment of buprenorphine withdrawal with the dopamine receptor agonist pramipexole

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318568

25 October 2018

Association between gene variants and response to buprenorphine maintenance treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318568

25 October 2018

Do alcohol-dependent individuals with DRD2 A1 allele have an increased risk of relapse? A pilot study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318568

25 October 2018

Acute effects of sublingual buprenorphine on brain responses to heroin-related cues in early-abstinent heroin addicts: an uncontrolled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318568

25 October 2018

Dopamine release in response to a psychological stress in humans and its relationship to early life maternal care: a positron emission tomography study using [11C]raclopride.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318568

25 October 2018

Relapse to drug-seeking: neural and molecular mechanisms.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318568

25 October 2018

[3H]naloxone binding in the human brain: alcoholism and the TaqI A D2 dopamine receptor polymorphism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318568

25 October 2018

Bromocriptine in the treatment of alcoholics with the D2 dopamine receptor A1 allele

1 reference

https://pubmed.ncbi.nlm.nih.gov/25664200

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.4172/2155-6105.1000185

1 reference

Europe PubMed Central

6 August 2017

1 reference

Europe PubMed Central

6 August 2017

1 reference

Europe PubMed Central

6 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35053937&oldid=1528014266"